We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sickle Cell Drug IMR-687 Shows Promise in Clinical Trial

News   Jun 20, 2019 | Original story from University of Connecticut

 
Sickle Cell Drug IMR-687 Shows Promise in Clinical Trial
 
 
 

RELATED ARTICLES

Rearranging Chromosomes – Does It Affect Their Function?

News

Molecular biologists long thought that domains in the genome’s 3D organization control how genes are expressed. After studying highly rearranged chromosomes in fruit flies, researchers now reveal that while this is the case for some genes, their results challenge the generality of this for many others.

READ MORE

Gaining Insight Into Sun-induced DNA Damage and Cell Repair

News

A team has published a breakthrough article that provides a better understanding of the dynamic process by which sunlight-induced DNA damage is recognized by the molecular repair machinery in cells as needing repair.

READ MORE

Marathon-running Molecule Set to Accelerate the Race for Novel Neurological Drugs

News

Two proteins that activate the fastest molecule in our nerve cells have been identified by researchers at University of Warwick. This mechanism is responsible for transport through our nervous system. This finding could lead to a new therapeutic treatments for people with hereditary spastic paraplegia and other neurological disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE